Skip to main content
  • Create new account
  • Reset your password

Search

Home
  • DE
  • EN

Hauptnavigation

Back
  • News
  • Topics
    • Chemistry & Life Sciences
    • Human Resources & Career
    • Logistics & Supply Chain
    • Markets & Companies
    • Plant Construction & Process Technology
    • Research & Innovation
    • Sites & Services
    • Strategy & Management
  • Publications
    • CHEManager International
  • Products
    • Chemicals & Distribution
    • Information Technology
    • Logistics
    • Production
    • Research / Laboratory
    • Services
  • Companies
  • Multimedia
    • Books
    • Webinars
    • Whitepaper
    • Webcast
    • Podcasts
  • Events
  • Jobs

Keyword: GSK redraws Shionogi deal

News

GSK Raises Bet on AIDS Drug with New Shionogi Deal

29.10.2012 - GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan's Shionogi, giving it a much bigger economic interest in the new product...

Most read articles

Covestro Agrees to Negotiations with ADNOC

Arxada Appoints Sanjeev Rastogi as CEO

LyondellBasell Plans Permanent Closure of PP Plant in Italy

Lonza-CEO Ruffieux to Leave Swiss CDMO

Brenntag Acquires South African Distributor Chemgrit

Top Feature

  • The Use of Evonik’s Catalysts to Manufacture TFA-free Margarines

    Evonik Industries AG
  • New Powerhouse from the Presto Series

    JULABO GmbH
  • Behavior Based Safety

    EFESO Consulting
  • How CDMOs Can Contribute to Pharma Supply even Better

    Aenova Holding GmbH
  • Innovative Acetate Range

    Dr. Paul Lohmann GmbH & Co. KGaA

Media Kit

Advertising Opportunities Print, Digital & Content Solutions

Social Media

LinkedIn | X (Twitter)

Top Feature

  • The Use of Evonik’s Catalysts to Manufacture TFA-free Margarines

    Evonik Industries AG
  • New Powerhouse from the Presto Series

    JULABO GmbH
  • Behavior Based Safety

    EFESO Consulting
  • How CDMOs Can Contribute to Pharma Supply even Better

    Aenova Holding GmbH
  • Innovative Acetate Range

    Dr. Paul Lohmann GmbH & Co. KGaA

Media Kit

Advertising Opportunities Print, Digital & Content Solutions

Social Media

LinkedIn | X (Twitter)

Wiley

Copyright 2001-2023

Fußbereichsmenü

Back
  • Imprint
  • Data Protection
  • Terms and Conditions
  • About us
  • Media Kit
  • Newsletter
  • Contact
  • Home

ProPhysik Revive Banner

sempay_Loh
Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!